Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients.

ABSTRACT: Passive surveillance data had signaled the possibility of gastrointestinal adverse events occurring after the administration of high-dose inactivated influenza vaccine (IIV-HD). However, in a large, prospective randomized clinical trial, rates of serious gastrointestinal events were no greater among IIV-HD recipients than among those who received a standard-dose influenza vaccine.

SUBMITTER: Talbot HK 

PROVIDER: S-EPMC6007273 | biostudies-other | 2018 Jun

REPOSITORIES: biostudies-other